VHL is often mutated in Von Hippel–Lindau disease, possesses E3 ubiquitin ligase activity, and acts as an adaptor of the Cullin-2 (CUL2) RING ubiquitination complex. Here, CUL2 is linked to von Hippel-Lindau disease.